| [1] |
Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death [J]. Cell, 2012, 149(5): 1060-1072.
|
| [2] |
Tang D, Chen X, Kang R, et al. Ferroptosis: molecular mechanisms and health implications [J]. Cell Res, 2021, 31(2): 107-125.
|
| [3] |
Seibt T, Wahida A, Hoeft K, et al. The biology of ferroptosis in kidney disease [J]. Nephrol Dial Transplant, 2024, 39(11): 1754-1761.
|
| [4] |
van Swelm RPL, Wetzels JFM, Swinkels DW. The multifaceted role of iron in renal health and disease [J]. Nat Rev Nephrol, 2020, 16(2): 77-98.
|
| [5] |
van Raaij SEG, Srai SKS, Swinkels DW, et al. Iron uptake by ZIP8 and ZIP14 in human proximal tubular epithelial cells [J]. Biometals, 2019, 32(2): 211-226.
|
| [6] |
Li S, Huang Y. Ferroptosis: an iron-dependent cell death form linking metabolism, diseases, immune cell and targeted therapy [J]. Clin Transl Oncol, 2022, 24(1): 1-12.
|
| [7] |
Soofi A, Li V, Beamish JA, et al. Renal-specific loss of ferroportin disrupts iron homeostasis and attenuates recovery from acute kidney injury [J]. Am J Physiol Renal Physiol, 2024, 326(2): F178-F188.
|
| [8] |
Xu Q, Li ZL, Zhang YL, et al. Kidney hepcidin protects the collecting duct against ferroptosis in ischemia/reperfusion-induced acute kidney injury [J]. Kidney Int, 2025, 108(3): 394-410.
|
| [9] |
Hou W, Xie Y, Song X, et al. Autophagy promotes ferroptosis by degradation of ferritin [J]. Autophagy, 2016, 12(8): 1425-1428.
|
| [10] |
Pope LE, Dixon SJ. Regulation of ferroptosis by lipid metabolism [J]. Trends Cell Biol, 2023, 33(12): 1077-1087.
|
| [11] |
Naowarojna N, Wu TW, Pan Z, et al. Dynamic regulation of ferroptosis by lipid metabolism [J]. Antioxid Redox Signal, 2023, 39(1-3): 59-78.
|
| [12] |
Nüsken E, Voggel J, Saschin L, et al. Kidney lipid metabolism: impact on pediatric kidney diseases and modulation by early-life nutrition [J]. Pediatr Nephrol, 2025, 40(6): 1839-1852.
|
| [13] |
Wang Y, Zhang M, Bi R, et al. ACSL4 deficiency confers protection against ferroptosis-mediated acute kidney injury [J]. Redox Biol, 2022, 51: 102262.
|
| [14] |
Lin J, Lai Y, Lu F, et al. Targeting ACSLs to modulate ferroptosis and cancer immunity [J]. Trends Endocrinol Metab, 2025, 36(7): 677-690.
|
| [15] |
Chen X, Kang R, Kroemer G, et al. Organelle-specific regulation of ferroptosis [J]. Cell Death Differ, 2021, 28(10): 2843-2856.
|
| [16] |
Li J, Cao F, Yin HL, et al. Ferroptosis: past, present and future [J]. Cell Death Dis, 2020, 11(2): 88.
|
| [17] |
Chen X, Li J, Kang R, et al. Ferroptosis: machinery and regulation [J]. Autophagy, 2021, 17(9): 2054-2081.
|
| [18] |
Chen X, Yu C, Kang R, et al. Cellular degradation systems in ferroptosis [J]. Cell Death Differ, 2021, 28(4): 1135-1148.
|
| [19] |
Bersuker K, Hendricks JM, Li Z, et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis [J]. Nature, 2019, 575(7784): 688-692.
|
| [20] |
Lv Y, Liang C, Sun Q, et al. Structural insights into FSP1 catalysis and ferroptosis inhibition [J]. Nat Commun, 2023, 14(1): 5933.
|
| [21] |
Mishima E, Nakamura T, Doll S, et al. Recommendations for robust and reproducible research on ferroptosis [J]. Nat Rev Mol Cell Biol, 2025, 26(8): 615-630.
|
| [22] |
Kraft VAN, Bezjian CT, Pfeiffer S, et al. GTP cyclohydrolase 1/tetrahydrobiopterin counteract ferroptosis through lipid remodeling [J]. ACS Cent Sci, 2020, 6(1): 41-53.
|
| [23] |
Wei X, Yi X, Zhu XH, et al. Posttranslational modifications in ferroptosis [J]. Oxid Med Cell Longev, 2020, 2020: 8832043.
|
| [24] |
Vasquez-Vivar J, Shi Z, Tan S. Tetrahydrobiopterin in cell function and death mechanisms [J]. Antioxid Redox Signal, 2022, 37(1-3): 171-183.
|
| [25] |
Zheng J, Conrad M. The metabolic underpinnings of ferroptosis [J]. Cell Metab, 2020, 32(6): 920-937.
|
| [26] |
Mao C, Liu X, Zhang Y, et al. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer [J]. Nature, 2021, 593(7860): 586-590.
|
| [27] |
Granata S, Votrico V, Spadaccino F, et al. Oxidative stress and ischemia/reperfusion injury in kidney transplantation: focus on ferroptosis, mitophagy and new antioxidants [J]. Antioxidants (Basel), 2022, 11(4): 769.
|
| [28] |
Malek M, Nematbakhsh M. Renal ischemia/reperfusion injury; from pathophysiology to treatment [J]. J Renal Inj Prev, 2015, 4(2): 20-27.
|
| [29] |
Wang J, Liu Y, Wang Y, et al. The cross-link between ferroptosis and kidney diseases [J]. Oxid Med Cell Longev, 2021, 2021: 6654887.
|
| [30] |
Baker ML, Cantley LG. Adding insult to injury: the spectrum of tubulointerstitial responses in acute kidney injury [J]. J Clin Invest, 2025, 135(6): e188358.
|
| [31] |
Fan Q, Liu D, Chu C, et al. Vaccarin alleviates renal ischemia-reperfusion injury by inhibiting inflammation and ferroptosis [J]. Int Immunopharmacol, 2025, 153: 114463.
|
| [32] |
Nakazawa D, Masuda S, Nishibata Y, et al. Neutrophils and NETs in kidney disease [J]. Nat Rev Nephrol, 2025, 21(6): 383-398.
|
| [33] |
Chen Y, Fang ZM, Yi X, et al. The interaction between ferroptosis and inflammatory signaling pathways [J]. Cell Death Dis, 2023, 14(3): 205.
|
| [34] |
Zhao Y, Wang C, Yang T, et al. Chlorogenic acid alleviates chronic stress-induced duodenal ferroptosis via the inhibition of the IL-6/JAK2/STAT3 signaling pathway in rats [J]. J Agric Food Chem, 2022, 70(14): 4353-4361.
|
| [35] |
Vallés PG, Gil Lorenzo AF, Garcia RD, et al. Toll-like receptor 4 in acute kidney injury [J]. Int J Mol Sci, 2023, 24(2): 1415.
|
| [36] |
Zhao Z, Li G, Wang Y, et al. Cytoplasmic HMGB1 induces renal tubular ferroptosis after ischemia/reperfusion [J]. Int Immunopharmacol, 2023, 116: 109757.
|
| [37] |
Yang L, Liu Y, Zhou S, et al. Novel insight into ferroptosis in kidney diseases [J]. Am J Nephrol, 2023, 54(5-6): 184-199.
|
| [38] |
Ng C, Kim M, Yanti, et al. Oxidative stress and NRF2 signaling in kidney injury [J]. Toxicol Res, 2025, 41(2): 131-147.
|
| [39] |
Zhang J, Zhang M, Tatar M, et al. Keap1-independent Nrf2 regulation: a novel therapeutic target for treating kidney disease [J]. Redox Biol, 2025, 82: 103593.
|
| [40] |
Hu Z, Hao W, Dai W, et al. Nrf2 alleviates colistin-induced nephrotoxicity by suppressing ferroptosis via GPX4-mediated lipid peroxidation and mitochondrial protection [J]. J Agric Food Chem, 2025, 73(24): 15281-15295.
|
| [41] |
Nezu M, Souma T, Yu L, et al. Transcription factor Nrf2 hyperactivation in early-phase renal ischemia-reperfusion injury prevents tubular damage progression [J]. Kidney Int, 2017, 91(2): 387-401.
|
| [42] |
Liu W, Xiong Z, Fu T, et al. Regulation of renal ischemia-reperfusion injury and tubular epithelial cell ferroptosis by pparγ m6a methylation: mechanisms and therapeutic implications [J]. Biol Direct, 2024, 19(1): 99.
|
| [43] |
Tao W, Lu Y, Xiao R, et al. LncRNA HMOX1 alleviates renal ischemia-reperfusion-induced ferroptotic injury via the miR-3587/HMOX1 axis [J]. Cell Signal, 2024, 119: 111165.
|
| [44] |
Ma Y, Fei S, Chen X, et al. Chemerin attenuates acute kidney injury by inhibiting ferroptosis via the AMPK/NRF2/SLC7A11 axis [J]. Commun Biol, 2024, 7(1): 1679.
|
| [45] |
Zhang LM, Liu XM, Guo DW, et al. FBXW7- mediated downregulation of GPX4 aggravates acute kidney injury following ischemia-reperfusion [J]. Inflammation, 2024, 48(3): 1484-1498.
|
| [46] |
Feng J, Kong R, Yang Y, et al. March6 protects against acute kidney injury by suppressing renal tubular epithelial cell ferroptosis through the destabilization of P53 and ACSL4 proteins [J]. Inflammation, 2025, 48(6): 4172-4188.
|
| [47] |
Wang K, Deng Y, Xu C, et al. ZNRF2 integrates ubiquitination-driven ferroptosis and mitochondrial quality control in renal ischemia-reperfusion injury [J]. Biomed Pharmacother, 2025, 192: 118584.
|
| [48] |
Zhang Y, Huang H, Li N, et al. Reticulon 3 deficiency induces ferroptosis via chaperone-mediated autophagy in ischemia-reperfusion induced acute kidney injury [J]. Free Radic Biol Med, 2026, 242: 9-20.
|
| [49] |
Xie S, Zou W, Liu S, et al. Site 1 protease aggravates acute kidney injury by promoting tubular epithelial cell ferroptosis through SIRT3-SOD2-mtROS signaling [J]. FEBS J, 2024, 291(7): 1575-1592.
|
| [50] |
Zhang Y, Xing J, Yao L, et al. Reprogramming iron metabolism via the RIG-I/c-Myc/FTH axis mitigates renal ischemia-reperfusion injury [J]. Antioxid Redox Signal, 2025, 43(10-12): 622-636.
|
| [51] |
Zhang YL, Li XY, Tang TT, et al. Metabolic dysregulation of 27-hydroxycholesterol sensitizes proximal tubular epithelial cells to ferroptosis in ischemic acute kidney injury [J]. J Am Soc Nephrol, 2026, 37(3): 445-459.
|
| [52] |
Ma TL, Chen JX, Zhu P, et al. Focus on ferroptosis regulation: exploring novel mechanisms and applications of ferroptosis regulator [J]. Life Sci, 2022, 307: 120868.
|
| [53] |
Stockwell BR. Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications [J]. Cell, 2022, 185(14): 2401-2421.
|
| [54] |
Wen RJ, Dong X, Zhuang HW, et al. Baicalin induces ferroptosis in osteosarcomas through a novel Nrf2/xCT/GPX4 regulatory axis [J]. Phytomedicine, 2023, 116: 154881.
|
| [55] |
Ma L, Liu X, Zhang M, et al. Paeoniflorin alleviates ischemia/reperfusion induced acute kidney injury by inhibiting SLC7A11-mediated ferroptosis [J]. Int Immunopharmacol, 2023, 116: 109754.
|
| [56] |
Deng Y, Zeng L, Liu H, et al. Silibinin attenuates ferroptosis in acute kidney injury by targeting FTH1 [J]. Redox Biol, 2024, 77: 103360.
|
| [57] |
Qi Y, Zheng J, Zi Y, et al. Loureirin C improves mitochondrial function by promoting NRF2 nuclear translocation to attenuate oxidative damage caused by renal ischemia-reperfusion injury [J]. Int Immunopharmacol, 2024, 138: 112596.
|
| [58] |
Wei JP, Zhao B, Jiang ZJ, et al. Luteolin mitigates renal ischemia-reperfusion injury via anti-inflammatory, anti-apoptotic, and Nrf2/HO-1-mediated antioxidant effects [J]. Eur J Pharmacol, 2025, 999: 177676.
|
| [59] |
Chen Q, Guo J, Han S, et al. Cordycepin alleviates renal ischemia-reperfusion injury by suppressing the p38/JNK signaling pathway [J]. Int Immunopharmacol, 2025, 150: 114264.
|
| [60] |
Sun Z, Zhang F, Gao Z, et al. Liraglutide alleviates ferroptosis in renal ischemia reperfusion injury via inhibiting macrophage extracellular trap formation [J]. Int Immunopharmacol, 2024, 142(Pt B): 113258.
|
| [61] |
Tschuck J, Tonnus W, Gavali S, et al. Seratrodast inhibits ferroptosis by suppressing lipid peroxidation [J]. Cell Death Dis, 2024, 15(11): 853.
|
| [62] |
张方圆，刘刚. 右美托咪定通过激活Nrf2/HO-1/GPX4通路抑制肾小管上皮细胞的铁死亡[J]. 南方医科大学学报，2024, 44(6): 1135-1140.
|
| [63] |
Zhang J, Ren X, Nie Z, et al. Dual-responsive renal injury cells targeting nanoparticles for vitamin E delivery to treat ischemia reperfusion-induced acute kidney injury [J]. J Nanobiotechnology, 2024, 22(1): 626.
|
| [64] |
Feng W, Zhu N, Xia Y, et al. Melanin-like nanoparticles alleviate ischemia-reperfusion injury in the kidney by scavenging reactive oxygen species and inhibiting ferroptosis [J]. iScience, 2024, 27(4): 109504.
|
| [65] |
Huang Q, Ru Y, Luo Y, et al. Identification of a targeted ACSL4 inhibitor to treat ferroptosis-related diseases [J]. Sci Adv, 2024, 10(13): eadk1200.
|
| [66] |
Zuo Z, Luo M, Liu Z, et al. Selenium nanoparticles alleviate renal ischemia/reperfusion injury by inhibiting ferritinophagy via the XBP1/NCOA4 pathway [J]. Cell Commun Signal, 2024, 22(1): 376.
|
| [67] |
Qin J, Li Z, Feng Y, et al. Reactive oxygen species-scavenging mesoporous poly(tannic acid) nanospheres alleviate acute kidney injury by inhibiting ferroptosis [J]. ACS Biomater Sci Eng, 2024, 10(9): 5856-5868.
|